FDA Output
FDA Output, April 2025
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in April 2025. Updated April 24, 2025.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways
Start Trial
Investors & Dealmaking
At the X-Summit: The Business Case for Investing in Women’s Health
Women’s Health Access Matters (WHAM) has produced financial data on investment trends in women’s health start-ups, with the aim of highlighting the field’s huge business opportunity.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.
Learn More
ICYMI
Abbott’s Advances in Leadless Pacing
Abbott’s Aveir Conduction System Pacing leadless pacemaker system is in early feasibility trials. Excerpted from our recent feature article "Keeping the Beat".